http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010520309-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate | 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2010520309-A |
titleOfInvention | Modulation of complement system activation to treat bleeding-related inflammation |
abstract | The invention relates to a method of treating synovitis and / or bleeding-related inflammation, reducing its occurrence, reducing its severity, or delaying its onset or progression, particularly in a subject in need thereof A composition is provided. The composition comprises an amount of an agent effective to inhibit or reduce complement pathway activation, and optionally other coagulation factors, other hemostatic factors, and / or other anti-inflammatory agents including a second anti-inflammatory agent. Contains therapeutic agents and methods use them. |
priorityDate | 2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1071.